From Manganism to Manganese-Induced Parkinsonism: A Conceptual Model Based on the Evolution of Exposure
- 724 Downloads
Manganism is a distinct medical condition from Parkinson’s disease. Manganese exposure scenarios in the last century generally have changed from the acute, high-level exposure conditions responsible for the occurrence of manganism to chronic exposure to much lower levels. Such chronic exposures may progressively extend the site of manganese deposition and toxicity from the globus pallidus to the entire area of the basal ganglia, including the substantia nigra pars compacta involved in Parkinson’s disease. The mechanisms of manganese neurotoxicity from chronic exposure to very low levels are not well understood, but promising information is based on the concept of susceptibility that may place individuals exposed to manganese at a higher risk for developing Parkinsonian disturbances. These conditions include mutations of genes which play important pathogenetic roles in both Parkinsonism and in the regulation of manganese transport and metabolism. Liver function is also important in manganese-related neurotoxicity and sub-clinical impairment may increase the risk of Parkinsonism. The purpose and scope of this report are to explore the literature concerning manganese exposure and potential subclinical effects and biological pathways, impairment, and development of diseases such as Parkinsonism and manganism. Inhalation and ingestion of manganese will be the focus of this report.
KeywordsManganism Manganese poisoning Parkinsonian disorders Occupational exposure Neurotoxicity
The findings and conclusions of this report are those of the authors and do not necessarily represent the views of the National Institute for Occupational Safety and Health.
- ACGIH®. (2009). TLVs® and BEIs®, ACGIH®. Cincinnati, OH.Google Scholar
- Alves, G., Müller, B., Herlofson, K., Hogenesch, I., Telstad, W., Aarsland, D., et al. (2009). Incidence of Parkinson’s disease in Norway. The Norwegian ParkWest study. Journal of Neurology, Neurosurgery, and Psychiatry [Epub ahead of print].Google Scholar
- Couper, J. (1837). On the effects of black oxide of manganese when inhaled into the lungs. British Annals of Medicine and Pharmacology, 1, 41–42.Google Scholar
- da Silva, C. J., da Rocha, A. J., Jeronymo, S., Mendes, M. F., Milani, F. T., Maia, A. C., Jr., et al. (2007). A preliminary study revealing a new association in patients undergoing maintenance hemodialysis: manganism symptoms and T1 hyperintense changes in the basal ganglia. American Journal of Neuroradiology, 28(8), 1474–1479.CrossRefPubMedGoogle Scholar
- Dorman, D. C., Brenneman, K. A., McElveen, A. M., Lynch, S. E., Roberts, K. C., & Wong, B. A. (2002). Olfactory transport: a direct route of delivery of inhaled manganese phosphate to the rate brain. Journal of Toxicology and Environmental Health. Part A, 65(20), 1493–1511.CrossRefPubMedGoogle Scholar
- Edsall, D. L., Wilbur, F. P., & Drinker, C. K. (1919). The occurrence, course and prevention of chronic manganese poisoning. Journal of Industrial Hygiene, 1, 183–193.Google Scholar
- EPA. (2003). Health effects support document for manganese. EPA822R03003, U.S. Environmental Protection Agency, Washington DC. http://www.epa.gov/safewater/ccl/pdfs/reg_determine1/support_cc1_magnese_healtheffects.pdf. Accessed 10 July 2009.
- Golub, M. S., Hogrefe, C. E., Germann, S. L., Tran, T. T., Beard, J. L., Crinella, F. M., et al. (2005). Neurobehavioral evaluation of rhesus monkey infants fed cow’s milk formula, soy formula, or soy formula with added manganese. Neurotoxicology and Teratology, 27(4), 615–627.CrossRefPubMedGoogle Scholar
- Grandjean, P., Bellinger, D., Bergman, A., Cordier, S., Davey-Smith, G., Eskenazi, B., et al. (2007). The Faroes Statement: Human health effects of developmental exposure to chemicals in our environment. Basic & Clinical Pharmacology & Toxicology, 102(2), 73–75.Google Scholar
- Harper, P. S. (2002). Huntington’s disease: A historical background. In G. Bates, P. S. Harper, & L. Jones (Eds.), Huntington’s disease (3rd edn., pp. 3–24). Oxford: Oxford University Press. ISBN 0-19-851060-8.Google Scholar
- IEH/IOM. (2004). Institute for Environment and Health/Institute of Occupational Medicine Occupational exposure limits: Criteria document for manganese and inorganic manganese compounds (Web Report W17), Leicester, UK, MRC Institute for Environment and Health. http://www.le.ac.uk/ieh. Accessed 10 July 2009.
- IUPAC. (1993). International Union of Pure and Applied Chemistry, Clinical Chemistry Division, Commission on Toxicology, Glossary for Chemists of Terms Used in Toxicology (IUPAC Recommendations 1993). Pure and Applied Chemistry, 65(9), 2003–2122.Google Scholar
- Klos, K. J., Ahlskog, J. E., Josephs, K. A., Fealey, R. D., Cowl, C. T., & Kumar, N. (2005). Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: Probable manganese neurotoxicity. Archives of Neurology, 62(9), 1385–1390.CrossRefPubMedGoogle Scholar
- Li, G. J., Zhang, L., Lu, L., Wu, P., & Zheng, W. (2004). Occupational exposure to welding fume among welders: Alterations of manganese, iron, zinc, copper, and lead in body fluids and the oxidative stress status. Journal of Occupational and Environmental Medicine, 46, 241–248.CrossRefPubMedGoogle Scholar
- Lönnerdal, B. (1994). Manganese nutrition of infants. In D. J. Klimis-Tavantzis (Ed.), Manganese in health and disease (pp. 176–191). Boca Raton, FL: CRC Press.Google Scholar
- Lucchini, R., Albini, E., Benedetti, L., Borghesi, S., Coccaglio, R., Malara, E. C., et al. (2007a). High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. American Journal of Industrial Medicine, 50, 788–800.CrossRefPubMedGoogle Scholar
- Lucchini, R., & Zimmerman, N. (2009). Lifetime cumulative exposure as a threat for neurodegeneration: Need for prevention strategies on a global scale. Neurotoxicology. doi: 10.1016/j.neuro.2009.10.003.
- Øygard, K., Riise, T., Moen, B., & Engelsen, B. A. (1992). Occurrence of Parkinson’s disease (PD) and Parkinsonism (P) in Sauda community. Proceedings of the symposium on manganese toxicity (pp. 179–182). International Manganese Institute, Paris, France.Google Scholar
- Park, J. D., Chung, Y. H., Kim, C. Y., Ha, C. S., Yang, S. O., Khang, H. S., et al. (2007). Comparison of high MRI T1 signals with manganese concentration in brains of cynomolgus monkeys after 8 months of stainless steel welding-fume exposure. Inhalation Toxicology, 19, 965–971.CrossRefPubMedGoogle Scholar
- Rodier, J. (1955). Manganese poisoning in Moroccan miners. British Journal of Industrial Medicine, 12.Google Scholar
- Roth, J. A. (this issue). Are there common biochemical and molecular mechanisms controlling manganism and Parkinsonism? Neuromolecular Medicine. doi: 10.1007/s12017-009-8088-8.
- Von Campenhausen, S., Bornschein, B., Wick, R., Botzel, K., Sampaio, C., Poewe, W., et al. (2005). Prevalence and High Prevalence of Parkinsonian Disorders incidence of Parkinson’s disease in Europe. Prevalence and high prevalence of Parkinsonian disorders incidence of Parkinson’s disease in Europe, 15, 473–490.CrossRefGoogle Scholar
- Von Jaksch, R. (1909). Ueber gehaufte diffuse Erkrankun- gen des Gehirns und Ruckenmarks, an den Typus der multiplen Sklerose mahnend, welche durch eine besondere Aetiologie gekennzeichnet sind. Klein Rundsch, 15, 729–733 (in German).Google Scholar
- Wexler, A. (2008). The woman who walked Into the sea. Huntington’s and the making of a genetic disease (pp. 288). Yale University Press. ISBN 9780300105025.Google Scholar
- WHO. (1981). Manganese. Environmental health criteria 17. Geneva, Switzerland: World Health Organization.Google Scholar
- WHO. (2004). Manganese in drinking-water. Background document for development of WHO guidelines for drinking-water quality. World Health Organization. WHO/SDE/WSH/03.04/104. http://www.who.int/water_sanitation_health/dwq/chemicals/manganese.pdf. Accessed 10 July 2009.
- Yokel, R. A. (this issue). Manganese flux across the blood–brain barrier. Neuromolecular Medicine. doi: 10.1007/s12017-009-8101-2.